also a history of photosensitivity. There was history of similar complaints in the other sibling who was an 18-year-old male. In the elder sibling, these lesions first started in the retroauricular area at the age of 5-6 years and then gradually spread to involve neck, upper limbs, trunk, and lower limbs over a period of 2 months and he also gave a history of recurrent chest infections and photosensitivity.
INTRODUCTION
E pidermodysplasia verruciformis (EV), first described in 1922 by Lewandowski and Lutz, is a rare genetic disease. It is characterized by a particular susceptibility to cutaneous infections with human papilloma virus (HPV) types in the genus β which do not produce clinical lesions in immunocompetent individuals. The HPV detected in EV are 3, 5, 8 (most frequently detected) 9, 12, 14, 15, 17, 19-25, 36-38, 47, 49, 50, etc. The disease usually manifests in childhood with highly polymorphic, widespread lesions. [1] Clinically, it presents with a characteristic combination of pityriasis versicolor-like lesions, reddish verruca-like and seborrheic keratosis-like plaques with a potential for malignant transformation. [2] 
CASE REPORT
A 12-year-old male boy, a product of consanguineous marriage, presented with multiple, light brown, and flat white lesions on face and forehead since last 5-6 years; initially it started with flat white lesions on the face which was followed by light brown lesions on forehead within a period of 2 months. There was the elder sibling which showed the features consistent with EV. The patient was put on isotretinoin after the investigations, along with sun protective measures. The elder sibling was put on 20 mg and the younger one on 10 mg of isotretinoin. On follow-up at 8 weeks, patients showed good response [Figures 1b and 2b].
DISCUSSION
EV is a rare genetic dermatosis which is caused by HPV. It usually begins in childhood and continues throughout the patient's lifetime. It presents clinically with a characteristic combination of pityriasis versicolor-like lesions, reddish verruca-like and seborrheic keratosis-like plaques. The lesions are preferentially located on sun-exposed sites. These patients show a defect of cell-mediated immunity that is specific toward the causative HPVs. [3] This inability to recognize and reject HPVs leads to lifelong lesions/ disease. Interestingly, these EV associated HPVs have been also involved in both benign and malignant proliferation of keratinocytes, as in the early stages of carcinogenesis. [4] The convincing oncogenic potential of HPV 5 and 8 in cutaneous malignancies of EV patients has evoked a considerable interest among clinicians and basic researchers for this rare genetic disorder as a model of cutaneous carcinogenesis. [2, 5] It is often associated with IgM deficiency and HIV infection. [3] However, the underlying defect in EV is still not well understood. This susceptibility of human keratinocytes to the HPV in EV is usually inherited through an autosomal recessive gene, and pathogenic mutations have been detected in EVER1/TMC6 and EVER2/TMC8 genes mapped to a locus on chromosome 17q 25 that encodes integral membrane proteins of unknown significance in the endoplasmic reticulum. [6] A high frequency of parental consanguinity is usual in most reported cases, and more than 30% of the siblings acquire the disease at some or the other stage. [5] Nevertheless, cases with autosomal dominant or X-linked inheritance too have been reported. [7] Mutated EVER1 and EVER2 genes in epidermodysplasia patients may control the infection of other viruses. [8] The role of etretinate and acitretin has been seen in numerous studies. [9, 10] However, these are only palliative treatments. Patients need a stringent sun protection and need to be observed lifelong to detect any premalignant or malignant change. Systemic retinoids have been used to maintain the remission in EV. [11] In our case, the lesions also showed a good response to isotretinoin along with sun protection.
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